Naama Hammel, None;
Andrew Tatham, Heidelberg Engineering GmbH (F);
Lucie Sharpsten, None;
Jeffrey Liebmann, Alcon Labortories Inc. (C), Allergan Inc. (C), Allergan Inc. (F), Bausch & Lomb Inc. (C), Bausch & Lomb Inc. (F), Carl Zeiss Meditech Inc. (F), Diopsys Inc. (C), Diopsys Inc. (F), Heidelberg Engineering GmbH (C), Heidelberg Engineering GmbH (F), Merz Pharmaceuticals Inc. (C), Optovue Inc. (F), Quark Pharmaceuticals Inc. (F), Reichert Inc. (F), Sensimed Inc. (F), Topcon Medical Systems Inc. (F), Valeant Pharmaceuticals Inc. (C);
Christopher Girkin, Carl Zeiss Meditech Inc. (F), Heidelberg Engineering GmbH (F), SOLX (F);
Felipe Medeiros, Alcon Laboratories Inc. (F), Alcon Laboratories Inc. (R), Allergan Inc. (C), Allergan Inc. (F), Allergan Inc. (R), Bausch & Lomb Inc. (F), Carl Zeiss Meditech Inc. (C), Carl Zeiss Meditech Inc. (F), Carl Zeiss Meditech Inc. (R), Heidelberg Engineering GmbH (F), Merck Inc. (F), National Eye Institute (F), Novartis Inc. (C), Reichert Inc. (F), Reichert Inc. (R), Sensimed Inc. (F), Topcon Medical Systems Inc. (F);
Robert Weinreb, Aerie Inc. (F), Alcon Laboratories Inc. (C), Allergan Inc. (C), Bausch & Lomb Inc. (C), Carl Zeiss Meditech Inc. (C), Carl Zeiss Meditech Inc. (F), Genentech Inc. (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Nidek Inc. (F), Novartis Inc. (F), Optovue Inc. (F), Sensimed Inc. (C), Topcon Medical Systems Inc. (C), Topcon Medical Systems Inc. (F);
Linda Zangwill, Carl Zeiss Meditech Inc. (F), Heidelberg Engineering GmbH (F), Nidek Inc. (F), Optovue Inc. (F), Topcon Medical Systems Inc. (F)